ECG Analysis System for Long QT Syndrome Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting long QT syndrome (LQTS) in patients are inadequate, particularly in clinical trials and hospital practices, as they rely on manual review of ECGs without demographic information, leading to potential biases and missed changes, and lack automated detection for drug-induced LQTS, which can cause sudden cardiac death.
Innovation Solution
A system and method that compares patient ECG data to multiple databases, including previous ECGs, known acquired LQTS characteristics, and genetic LQTS characteristics, while being sensitive to gender and ethnicity, to detect changes in QT interval, T-wave morphology, and U-wave morphology, and match drug effects, integrated into existing ECG management systems.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If ECGs are reviewed in a blinded fashion without demographic information, then the accuracy of the overreading process is improved, but significant changes in the ECG may be missed
Solution Approach 1:
The system segments the ECG review process into multiple stages: initial blinded automated analysis, demographic data integration, and comparative analysis against previous ECGs. This allows the benefits of blinded review to be maintained while systematically incorporating demographic context and historical data to detect significant changes.
Solution Approach 2:
The system implements feedback loops where automated analysis results are continuously refined by incorporating demographic information and comparing against historical ECG data. The system provides feedback to clinicians about significant changes detected, allowing them to focus on clinically relevant findings while maintaining the efficiency of automated blinded review.
2Reliability
If ECGs are reviewed in reverse chronological order, then changes common in myocardial infarction and ischemic heart disease are detected, but acquired LQTS caused by drugs over time is missed
Solution Approach 1:
The system dynamically adapts the analysis approach based on the clinical context and patient history. It can switch between reverse chronological review for acute conditions and forward chronological analysis for detecting gradual drug-induced changes. The system automatically adjusts the temporal analysis strategy based on the detected patterns and clinical indicators.
Solution Approach 2:
The system adds multiple temporal analysis dimensions by simultaneously performing both reverse chronological and forward chronological comparisons. It analyzes ECGs in multiple time directions and combines these perspectives to detect different types of changes, including both acute myocardial infarction patterns and gradual acquired LQTS progression.
3Ease of operation
If manual review of ECGs is performed without automated detection, then clinical judgment can be applied, but drug-induced LQTS and congenital LQTS cannot be reliably identified
Solution Approach 1:
The system introduces an automated intermediary analysis layer that processes ECGs using algorithms trained to detect LQTS patterns. This intermediary system performs preliminary automated detection and flagging of suspicious cases, which are then reviewed by clinicians. The automated system acts as a mediator that enhances clinical judgment by providing objective, consistent detection of subtle LQTS patterns that may be missed in manual review.
Solution Approach 2:
The system performs preliminary automated analysis of all ECGs to identify potential LQTS cases before they reach clinical review. By pre-processing and flagging suspicious ECGs with automated detection algorithms, the system prepares prioritized lists for clinicians, ensuring that potential LQTS cases are not missed while maintaining efficient use of clinical expertise.
4Measurement precision
If comprehensive databases including demographic information are used, then detection accuracy is improved, but system complexity increases
Solution Approach 1:
The system segments the comprehensive database into modular, organized components: demographic data modules, historical ECG modules, drug information modules, and genetic information modules. Each module can be independently accessed and processed, reducing the complexity of managing and querying the entire database while maintaining comprehensive analytical capabilities.
Data Source
AI summary
The present disclosure includes a system and method of detecting LQTS in a patient by comparing a collected set of ECG data from the patient to a plurality of databases of collected ECG data. The plurality of databases will include a database containing previous ECGs from the patient, a known acquired LQTS characteristics database, and a known genetic LQTS characteristics database. Comparing the patients ECG to these databases will facilitate the detection of such occurrences as changes in QT interval from success of ECGs, changes in T-wave morphology, changes in U-wave morphology and can match known genetic patterns of LQTS. The system and method is sensitive to patient gender and ethnicity, as these factors have been shown to effect LQTS, and is furthermore capable of matching a QT duration to a database of drug effects. The system and method is also easily integrated into current ECG management systems and storage devices.